SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as anticipation builds for the imminent launch of its next BlueBird satellite, marking the start of an accelerated deployment cadence. The community is highly optimistic, celebrating this "launch season" and believing the company is transitioning from vision to visible execution, with many forecasting a "green Christmas" for the stock. This excitement is set within a broader "space mania" in the market, fueled by potential government contracts and favorable U.S. space policy announcements.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis (AVNT CRYPTO) is actively trending due to its deep integration with Coinbase's Base app as a perpetual decentralized exchange and a recent listing on Robinhood, driving considerable community discussion. While many anticipate significant growth potential fueled by its Coinbase backing and innovations like an AI trading bot, a vocal segment expresses frustration over price volatility, perceived token unlocks, and accusations of market manipulation.

Starfighters Space Inc

Starfighters Space Inc (FJET) is generating significant buzz as a newly public "space stock," drawing investor attention amidst a broader uptrend in the aerospace sector. The community is actively discussing its unique capability to launch payloads using a supersonic aircraft fleet, while also noting its high volatility and some skepticism regarding its current financials and warrants. Many bulls anticipate a substantial long-term upside, often comparing it to other successful space ventures and speculating on its future potential.

Global X Funds - Global X DAX Germany ETF

Global X DAX Germany ETF

German equities, represented by DAX, are trending higher, fueled by robust technical buying at key support levels and fresh optimism from Germany's substantial debt reform plans aimed at boosting defense and infrastructure spending. The trading community is actively discussing textbook Elliott Wave "Blue Box" setups delivering strong upward reactions, with many anticipating continued impulsive rallies toward new all-time highs. This positive momentum is reinforced by expectations of an accommodative ECB and a broader rotation of capital into European markets.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending due to highly anticipated interim Phase 1 data for its obesity candidate, WVE-007, which demonstrated significant visceral fat reduction and muscle preservation with a favorable safety profile. The community is actively discussing its potential to disrupt the competitive GLP-1 market and is fueling acquisition speculation, especially following recent bullish analyst upgrades and notable insider buying.

Next Technology Holding, Inc. engages in the provision of software development services to the customers and bitcoin acquisition. The company was founded on March 28, 2019 and is headquartered in Shenzhen, China.

Next Technology Holding Inc.

Next Technology Holding Inc. is trending after clearing its Nasdaq listing concerns, with the exchange affirming its operational status and removing a major uncertainty. The community is actively discussing the substantial value of the company's Bitcoin treasury, which many perceive as highly undervalued relative to its market capitalization. Additionally, recent new AI service contracts and a relatively limited share float are contributing to speculative interest and comparisons to previous high-momentum market plays.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending sharply amid persistent acquisition rumors, notably involving Eli Lilly, and strong analyst upgrades touting its lead inflammatory bowel disease drug, obefazimod, as a potential blockbuster. Community discussions are abuzz with comparisons to other major biotech surges following positive Phase 3 data, reinforcing expectations for a significant buyout driven by the drug's compelling efficacy and safety profile in a high-demand market.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoin is currently a focal point for market participants, with intense debate centered on the Bank of Japan's anticipated interest rate decision and its potential to unwind yen carry trades, which some fear could trigger further price weakness. Countering this, growing institutional access via platforms like Vanguard allowing crypto ETF trading is fueling a bullish outlook, leading to a split in community sentiment over immediate price direction and future accumulation. The broader market is weighing these central bank dynamics against increasing mainstream adoption as Bitcoin navigates key technical levels.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is experiencing significant bullish momentum driven by widespread community anticipation of a year-end rally and increasing institutional interest. Recent developments like Hong Kong's plans to allow insurer crypto investments and major financial institutions building on its network underscore its growing role as a foundational layer. Despite this, some traders maintain caution, wary of potential short-term volatility and market manipulation.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending amidst robust market discussion driven by recent political rhetoric advocating for healthcare price reductions and ongoing uncertainty surrounding ACA subsidies. Community sentiment is divided, with some investors concerned about potential sector headwinds and tax loss selling, while others see the stock as undervalued given its strong fundamentals, institutional accumulation, and a recently reported positive compliance audit.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CRVO timber  
 
frick  well i had ample opportunity to get out   
 
5 on horizon

StockTwits Web

CervoMed Inc

 timber  
 
frick  well i had ample opportunity to get out   
 
5 on horizon

Chas Linder

@Stu_padasso would you prefer that they did not complete the Phase 3 trial?

StockTwits for iOS

 would you prefer that they did not complete the Phase 3 trial?

SteveO

@Stu_padasso if they dilute, that’s what it will be for.

 if they dilute, that’s what it will be for.

@SteveO_TX_to_FL yeah its just unfortunate that it will be at like 5 instead of a stronger position 
 
is what it is

 yeah its just unfortunate that it will be at like 5 instead of a stronger position 
 
is what it is

@SteveO_TX_to_FL could very well be tax selling   
easy enough stock to drive down and buy back in new year   
 
this would be preferable lok

 could very well be tax selling   
easy enough stock to drive down and buy back in new year   
 
this would be preferable lok

@Stu_padasso my preference is a partnership, merger, or acquisition.  But I am very willing to continue buying at these discounted prices!  If they do dilute and the price tanks, I will sell a bunch of other stocks and go almost all in.

Silver

 my preference is a partnership, merger, or acquisition.  But I am very willing to continue buying at these discounted prices!  If they do dilute and the price tanks, I will sell a bunch of other stocks and go almost all in.